Denmark· DK-28107190524
Bexarotene "Amdipharm"
A bexarotene product containing bexaroten, registered in Denmark by Amdipharm Limited. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Bexarotene is registered in 13 of 19 countries.
Countries holding a registration under ATC L01XF03 (bexarotene), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Bexarotene · ATC L01XF03
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Bexaroten
- Manufacturer
- Amdipharm Limited
- Country
- Denmark (DK)
- ATC code
- L01XF03
- ATC class
- Bexarotene
- Defined daily dose
- 0.54 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107190524
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
573 interactions on record for bexarotene.
Graded by severity as the source publishes them — 127 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bexarotene · interactions on record
573 records
- 127 severe
- 357 moderate
- 80 minor
- 9 info
Most severe, free to view
- EluxadolineA07DA06severe
- LiraglutidA08AX02severe
- SemaglutidA08AX03severe
- SitagliptinA10BH01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01XF03
Bexarotene, as other registers publish it.
- GermanyBexaroten CiplaCipla Europe Nv
- United StatesbexaroteneActavis Pharma, Inc.
- United StatesBexaroteneAmneal Pharmaceuticals NY LLC
- United StatesBexaroteneMylan Pharmaceuticals Inc.
- United StatesBexaroteneUpsher-Smith Laboratories, Inc.
- United StatesBexaroteneCamber Pharmaceuticals, Inc.
- United StatesBexaroteneAvKARE
- United StatesBexaroteneAmneal Pharmaceuticals NY LLC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7302bc84-8075-4f2b-bd60-6ba68717df45 GET /v1/drugs/7302bc84-8075-4f2b-bd60-6ba68717df45?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "kapsler, bløde",
"source": "dkma",
"strength": "75 mg",
"auth_role": "CMS",
"dk_drugid": "28107190524",
"substance": "Bexaroten",
"auth_procedure": "MRP",
"in_medicinpriser": true,
"registration_date_serial": "45615"
}See everything about bexarotene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.